Ibrance 125 mg

Ibrance 125 mg is a prescription medication used primarily to treat certain types of advanced breast cancer. It works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), which helps slow the growth and spread of cancer cells. Ibrance is typically prescribed as part of a combination therapy and requires careful medical supervision to optimize treatment outcomes and manage potential side effects effectively.